Vanguard amends 13G for 10X Genomics (NASDAQ: TXG) reporting 0 shares
Rhea-AI Filing Summary
10X Genomics Inc ownership filing: The Vanguard Group filed an amendment to a Schedule 13G reporting 0 shares beneficially owned of Common Stock, representing 0% of the class. The filing states Vanguard and related managed accounts have rights to dividends or sale proceeds but hold no >5% interest.
Positive
- None.
Negative
- None.
FAQ
What does Vanguard's Schedule 13G/A for TXG state about ownership?
Does the filing show Vanguard controls voting or disposition for TXG shares?
Is Vanguard acting on behalf of other investors in this Schedule 13G/A?
What is the legal significance of a Schedule 13G/A amendment by a large manager?
Who signed the Schedule 13G/A for Vanguard and when was it signed?